• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

June 14, 2016

Trending News Today: Federal Lawsuit Challenges ACA Requirement

Author(s):

Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

The Centers for Medicare and Medicaid Services released a proposal on Monday that would make antibiotic stewardship programs mandatory for health care facilities to help curb the overuse of antibiotics, or be ejected from Medicare, reported The Wall Street Journal. The proposal comes in the wake of the increasing concern over drug-resistant superbugs. This rule would make the programs mandatory for hospitals to get paid by Medicare.

Evergreen Health filed a lawsuit in the US District Court in Maryland against the federal government to avoid having to pay millions to larger insurers under the Affordable Care Act (ACA). According to The Washington Post, the Centers for Medicare and Medicaid Services (CMS) is requiring the company to pay $22 million to the Blue Cross and Blue Shield affiliate, CareFirst, which is a cost that would account for 26% of Evergreen’s 2015 revenue from premiums. “Risk adjustment was designed to stabilize the health insurance markets in the states but, in fact, CMS’s implementation of the program has done just the opposite,” said Chief Executive of Evergreen Health Peter Beilenson. “If the system isn’t changed in the immediate future, many of the country’s most innovative and most affordable health insurance companies could very well go out of business.”

An agreement between New York’s top state lawmakers and Democratic Governor Andrew Cuomo will expand access to breast cancer screening to help combat the disease, reported The Washington Post. The deal would require hospitals to expand the hours when mammograms are offered, and insurance companies will have to eliminate copays and deductibles for these screenings and tests. The proposal is expected to be officially approved this week. The priority to combat cancer followed Cuomo’s girlfriend, Food Network star Sandra Lee, receiving successful treatment. “When Sandy was diagnosed with breast cancer, she was lucky to have caught it early,” Cuomo said. “But not all women are that lucky, and many are not fortunate enough to have the flexibility in their schedule or the resources to fight this disease head on.”

Related Videos
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Primary biliary cholangitis -- Image credit: iushakovsky | stock.adobe.com
May 20th 2025

Linerixibat Significantly Improves PBC-Related Cholestatic Pruritus in Adult Patients

Gillian McGovern, Associate Editor
pharmacy focus oncology podcast
May 19th 2025

Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care

Alexandra Gerlach, Associate Editor
3d illustration - Bladder cancer cells - Image credit: PRB ARTS | stock.adobe.com
May 19th 2025

Anti-PD-1 Monoclonal Antibody With Standard of Care Improves Outcomes for BCG-Naïve Bladder Cancer

Kennedy Ferruggia, Assistant Editor
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Depiction of plaque build up on neurons within brain -- image credit: Dr_Microbe | stock.adobe.com
May 19th 2025

FDA Grants Market Clearance to Diagnostic Blood Test for Alzheimer Disease

Gillian McGovern, Associate Editor
NCCN Adds Naxitamab as Category 2A Recommendation for High-Risk Neuroblastoma
May 18th 2025

NCCN Adds Naxitamab as Category 2A Recommendation for High-Risk Neuroblastoma

Alana Hippensteele, Lead Editor
Related Content
Advertisement
Primary biliary cholangitis -- Image credit: iushakovsky | stock.adobe.com
May 20th 2025

Linerixibat Significantly Improves PBC-Related Cholestatic Pruritus in Adult Patients

Gillian McGovern, Associate Editor
pharmacy focus oncology podcast
May 19th 2025

Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care

Alexandra Gerlach, Associate Editor
3d illustration - Bladder cancer cells - Image credit: PRB ARTS | stock.adobe.com
May 19th 2025

Anti-PD-1 Monoclonal Antibody With Standard of Care Improves Outcomes for BCG-Naïve Bladder Cancer

Kennedy Ferruggia, Assistant Editor
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Depiction of plaque build up on neurons within brain -- image credit: Dr_Microbe | stock.adobe.com
May 19th 2025

FDA Grants Market Clearance to Diagnostic Blood Test for Alzheimer Disease

Gillian McGovern, Associate Editor
NCCN Adds Naxitamab as Category 2A Recommendation for High-Risk Neuroblastoma
May 18th 2025

NCCN Adds Naxitamab as Category 2A Recommendation for High-Risk Neuroblastoma

Alana Hippensteele, Lead Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.